Integrated Filing — IndAS

General information about company
Scrip Code	543980
NSE Symbol	JLHL
MSEI Symbol	NOTLISTED
ISIN	INE682M01012
Name of company	Jupiter Life Line Hospitals Limited
Type of company	Main Board
Class of security	Equity
Date of start of financial year	01-Apr-2024
Date of end of financial year	31-Mar-2025
Date of board meeting when results were approved	09-May-2025
Date on which prior intimation of the meeting for considering financial results was informed to the exchange	05-May-2025
Description of presentation currency	INR (in Actuals)
Reporting Type	Quarterly
Reporting Quarter	Fourth quarter
Nature of report standalone or consolidated	Standalone
Whether results are audited or unaudited for the quarter ended	Unaudited
Whether results are audited or unaudited for the Year to date for current period ended/year ended	Audited
Segment Reporting	Single segment
Description of single segment	Helathcare Services
Start date and time of board meeting	09-May-2025   15:00:00
End date and time of board meeting	09-May-2025   16:30:00
Whether cash flow statement is applicable on company	Yes
Type of cash flow statement	Cash Flow Indirect
Declaration of unmodified opinion or statement on impact of audit qualification	Declaration of unmodified opinion
Whether the company has any related party?	Yes
Whether the company has entered into any Related Party transaction during the selected half year for which it wants to submit disclosure?	Yes
(I) We declare that the acceptance of fixed deposits by the bans/Non-Banking Finance Company are at the terms uniformly applicable/offered to all shareholders/public	NA
(II) We declare that the scheduled commercial bank, as per RBI circular RBI/DBR/2015-16/19 dated March 03, 2016, has allowed additional interest of one per cent per annum, over and above the rate of interest mentioned in the schedule of interest rates on savings or a term deposits of banks staff and their exclusive associations as well as on deposits of Chairman, Chairman & Managing Director, Executive Director or such other Executives appointed for a fixed tenure.	NA
Whether the company is a high value debt listed entity according to regulation 15 (1A)?	No
(a) If answer to above question is Yes, whether complying with proviso to regulation 23 (9), i.e., submitting RPT disclosures on the day of results publication?
(b) If answer to above question is No, please explain the reason for not complying.
Whether the updated Related Party Transactions (RPT) Policy (in compliance with Reg. 23 of SEBI LODR) has been uploaded on the website of the Company?	Yes
Latest Date on which RPT policy is updated	2025-02-07
Indicate Company website link for updated RPT policy of the Company	https://www.jupiterhospital.com/wp-content/uploads/2023/12/Related-Party-Transaction-Policy.pdf
Whether statement on deviation or variation for proceeds of public issue, rights issue, preferential issue, qualified institutions placement etc. is applicable to the company for the current quarter?	No
No. of times funds raised during the quarter
Whether the disclosure for the Default on Loans and Debt Securities is applicable to the entity?	No
NA

Financial Results Ind-AS
Particulars		3 months/ 6 months ended (dd-mm-yyyy)	Year to date figures for current period ended (dd-mm-yyyy)
A	Date of start of reporting period	01-Jan-2025	01-Apr-2024
B	Date of end of reporting period	31-Mar-2025	31-Mar-2025
C	Whether results are audited or unaudited	Unaudited	Audited
D	Nature of report standalone or consolidated	Standalone	Standalone
Part I	Blue color marked fields are non-mandatory. For Consolidated Results, if the company has no figures for 3 months / 6 months ended, in such case zero shall be inserted in the said column.
1	Income
	Revenue from operations	2739130000	10599980000
	Other income	69520000	281380000
	Total income	2808650000	10881360000
2	Expenses
(a)	Cost of materials consumed	0	0
(b)	Purchases of stock-in-trade	494900000	1925910000
(c)	Changes in inventories of finished goods, work-in-progress and stock-in-trade	15410000	-14080000
(d)	Employee benefit expense	441370000	1772230000
(e)	Finance costs	40020000	86050000
(f)	Depreciation, depletion and amortisation expense	133770000	424080000
(f)	Other Expenses
1	Professional fees	647000000	2523950000
2	Others	418370000	1699780000
	Total other expenses	1065370000	4223730000
	Total expenses	2190840000	8417920000
3	Total profit before exceptional items and tax	617810000	2463440000
4	Exceptional items	0	0
5	Total profit before tax	617810000	2463440000
6	Tax expense
7	Current tax	139990000	604330000
8	Deferred tax	33350000	12090000
9	Total tax expenses	173340000	616420000
10	Net movement in regulatory deferral account balances related to profit or loss and the related deferred tax movement	0	0
11	Net Profit Loss for the period from continuing operations	444470000	1847020000
12	Profit (loss) from discontinued operations before tax	0	0
13	Tax expense of discontinued operations	0	0
14	Net profit (loss) from discontinued operation after tax	0	0
15	Share of profit (loss) of associates and joint ventures accounted for using equity method	0	0
16	Total profit (loss) for period	444470000	1847020000
17	Other comprehensive income net of taxes	-8580000	-8580000
18	Total Comprehensive Income for the period	435890000	1838440000
19	Total profit or loss, attributable to
	Profit or loss, attributable to owners of parent
	Total profit or loss, attributable to non-controlling interests
20	Total Comprehensive income for the period attributable to
	Comprehensive income for the period attributable to owners of parent
	Total comprehensive income for the period attributable to owners of parent non-controlling interests
21	Details of equity share capital
	Paid-up equity share capital	655660000	655660000
	Face value of equity share capital	10	10
27	Details of debt securities
22	Reserves excluding revaluation reserve		13569760000
23	Earnings per share
i	Earnings per equity share for continuing operations
	Basic earnings (loss) per share from continuing operations	6.78	28.17
	Diluted earnings (loss) per share from continuing operations	6.78	28.17
ii	Earnings per equity share for discontinued operations
	Basic earnings (loss) per share from discontinued operations	0	0
	Diluted earnings (loss) per share from discontinued operations	0	0
ii	Earnings per equity share
	Basic earnings (loss) per share from continuing and discontinued operations	6.78	28.17
	Diluted earnings (loss) per share from continuing and discontinued operations	6.78	28.17
24	Debt equity ratio
25	Debt service coverage ratio
26	Interest service coverage ratio
27	Disclosure of notes on financial results

Remarks
Debt equity ratio
Debt service coverage ratio
Interest service coverage ratio

Statement of Asset and Liabilities
Particulars		Year ended (dd-mm-yyyy)
Date of start of reporting period		01-Apr-2024
Date of end of reporting period		31-Mar-2025
Whether results are audited or unaudited		Audited
Nature of report standalone or consolidated		Standalone
	Assets
1	Non-current assets
	Property, plant and equipment	7088680000
	Capital work-in-progress	1625620000
	Investment property	0
	Goodwill	0
	Other intangible assets	43320000
	Intangible assets under development	0
	Biological assets other than bearer plants	0
	Investments accounted for using equity method	0
	Non-current financial assets
	Non-current investments	940340000
	Trade receivables, non-current	0
	Loans, non-current	0
	Other non-current financial assets	540530000
	Total non-current financial assets	1480870000
	Deferred tax assets (net)	0
	Other non-current assets	206160000
	Total non-current assets	10444650000
2	Current assets
	Inventories	181740000
	Current financial asset
	Current investments	1142680000
	Trade receivables, current	365560000
	Cash and cash equivalents	3674100000
	Bank balance other than cash and cash equivalents	1203470000
	Loans, current	0
	Other current financial assets	3790000
	Total current financial assets	6389600000
	Current tax assets (net)	0
	Other current assets	87430000
	Total current assets	6658770000
3	Non-current assets classified as held for sale	0
4	Regulatory deferral account debit balances and related deferred tax Assets	0
	Total assets	17103420000
	Equity and liabilities
1	Equity
	Equity attributable to owners of parent
	Equity share capital	655660000
	Other equity	13569760000
	Total equity attributable to owners of parent	14225420000
	Non controlling interest
	Total equity	14225420000
2	Liabilities
	Non-current liabilities
	Non-current financial liabilities
	Borrowings, non-current	742500000
	Trade payables, non-current
	(A) Total outstanding dues of micro enterprises and small enterprises	0
	(B) Total outstanding dues of creditors other than micro enterprises and small enterprises	0
	Total Trade payable	0
	Other non-current financial liabilities	623410000
	Total non-current financial liabilities	1365910000
	Provisions, non-current	38850000
	Deferred tax liabilities (net)	257510000
	Deferred government grants, Non-current	0
	Other non-current liabilities	0
	Total non-current liabilities	1662270000
	Current liabilities
	Current financial liabilities
	Borrowings, current	7500000
	Trade payables, current
	(A) Total outstanding dues of micro enterprises and small enterprises	101120000
	(B) Total outstanding dues of creditors other than micro enterprises and small enterprises	720440000
	Total Trade payable	821560000
	Other current financial liabilities	50910000
	Total current financial liabilities	879970000
	Other current liabilities	209600000
	Provisions, current	123670000
	Current tax liabilities (Net)	2490000
	Deferred government grants, Current	0
	Total current liabilities	1215730000
3	Liabilities directly associated with assets in disposal group classified as held for sale	0
4	Regulatory deferral account credit balances and related deferred tax liability	0
	Total liabilities	2878000000
	Total equity and liabilites	17103420000
	Disclosure of notes on assets and liabilities

Format for Reporting Segmenet wise Revenue, Results and Capital Employed along with the company results
Particulars		3 months/ 6 month ended (dd-mm-yyyy)	Year to date figures for current period ended (dd-mm-yyyy)
Date of start of reporting period		01-Jan-2025	01-Apr-2024
Date of end of reporting period		31-Mar-2025	31-Mar-2025
Whether accounts are audited or unaudited		Unaudited	Audited
Nature of report standalone or consolidated		Standalone	Standalone
1	Segment Revenue (Income)
	(net sale/income from each segment should be disclosed)
	Total Segment Revenue
	Less: Inter segment revenue
	Revenue from operations
2	Segment Result
	Profit (+) / Loss (-) before tax and interest from each segment
	Total Profit before tax
	i. Finance cost
	ii. Other Unallocable Expenditure net off Unallocable income
	Profit before tax
3	(Segment Asset - Segment Liabilities)
	Segment Asset
	Total Segment Asset
	Un-allocable Assets	null	null
	Net Segment Asset	null	null
4	Segment Liabilities
	Segment Liabilities
	Total Segment Liabilities
	Un-allocable Liabilities	null	null
	Net Segment Liabilities	null	null
	Disclosure of notes on segments

Other Comprehensive Income
Particulars		3 months/ 6 months ended (dd-mm-yyyy)	Year to date figures for current period ended (dd-mm-yyyy)
A	Date of start of reporting period	01-Jan-2025	01-Apr-2024
B	Date of end of reporting period	31-Mar-2025	31-Mar-2025
C	Whether results are audited or unaudited	Unaudited	Audited
D	Nature of report standalone or consolidated	Standalone	Standalone
	Other comprehensive income [Abstract]
1	Amount of items that will not be reclassified to profit and loss
1	Remeasurements of the net defined benefit plans	-11460000	-11460000
	Total Amount of items that will not be reclassified to profit and loss	-11460000	-11460000
2	Income tax relating to items that will not be reclassified to profit or loss	-2880000	-2880000
3	Amount of items that will be reclassified to profit and loss
1	NA	0	0
	Total Amount of items that will be reclassified to profit and loss	0	0
4	Income tax relating to items that will be reclassified to profit or loss	0	0
5	Total Other comprehensive income	-8580000	-8580000

Cash flow statement, indirect
Particulars				Year ended (dd-mm-yyyy)
A	Date of start of reporting period			2024-04-01
B	Date of end of reporting period			2025-03-31
C	Whether results are audited or unaudited			Unaudited
D	Nature of report standalone or consolidated			Standalone
Part I	Blue color marked fields are non-mandatory.
	Statement of cash flows
	Cash flows from used in operating activities
	Profit before tax			2463440000
	Adjustments for reconcile profit (loss)
	Adjustments for finance costs			86050000
	Adjustments for decrease (increase) in inventories			-14090000
	Adjustments for decrease (increase) in trade receivables, current			10170000
	Adjustments for decrease (increase) in trade receivables, non-current			87810000
	Adjustments for decrease (increase) in other current assets			-25850000
	Adjustments for decrease (increase) in other non-current assets			0
	Adjustments for other financial assets, non-current			38170000
	Adjustments for other financial assets, current			0
	Adjustments for other bank balances			0
	Adjustments for increase (decrease) in trade payables, current			50380000
	Adjustments for increase (decrease) in trade payables, non-current			0
	Adjustments for increase (decrease) in other current liabilities			0
	Adjustments for increase (decrease) in other non-current liabilities			-16990000
	Adjustments for depreciation and amortisation expense			424080000
	Adjustments for impairment loss reversal of impairment loss recognised in profit or loss			25770000
	Adjustments for provisions, current			0
	Adjustments for provisions, non-current			0
	Adjustments for other financial liabilities, current			0
	Adjustments for other financial liabilities, non-current			0
	Adjustments for unrealised foreign exchange losses gains			0
	Adjustments for dividend income			80000
	Adjustments for interest income			195830000
	Adjustments for share-based payments			0
	Adjustments for fair value losses (gains)			-18570000
	Adjustments for undistributed profits of associates			0
	Other adjustments for which cash effects are investing or financing cash flow			-44640000
	Other adjustments to reconcile profit (loss)			0
	Other adjustments for non-cash items			0
	Share of profit and loss from partnership firm or association of persons or limited liability partnerships			-47160000
	Total adjustments for reconcile profit (loss)			359220000
	Net cash flows from (used in) operations			2822660000
	Dividends received			0
	Interest paid			0
	Interest received			0
	Income taxes paid (refund)			623880000
	Other inflows (outflows) of cash			0
	Net cash flows from (used in) operating activities			2198780000
	Cash flows from used in investing activities
	Cash flows from losing control of subsidiaries or other businesses			0
	Cash flows used in obtaining control of subsidiaries or other businesses			0
	Other cash receipts from sales of equity or debt instruments of other entities			0
	Other cash payments to acquire equity or debt instruments of other entities			0
	Other cash receipts from sales of interests in joint ventures			0
	Other cash payments to acquire interests in joint ventures			0
	Cash receipts from share of profits of partnership firm or association of persons or limited liability partnerships			31180000
	Cash payment for investment in partnership firm or association of persons or limited liability partnerships			0
	Proceeds from sales of property, plant and equipment			710000
	Purchase of property, plant and equipment			2804120000
	Proceeds from sales of investment property			0
	Purchase of investment property			0
	Proceeds from sales of intangible assets			0
	Purchase of intangible assets			0
	Proceeds from sales of intangible assets under development			0
	Purchase of intangible assets under development			0
	Proceeds from sales of goodwill			0
	Purchase of goodwill			0
	Proceeds from biological assets other than bearer plants			0
	Purchase of biological assets other than bearer plants			0
	Proceeds from government grants			0
	Proceeds from sales of other long-term assets			843460000
	Purchase of other long-term assets			0
	Cash advances and loans made to other parties			0
	Cash receipts from repayment of advances and loans made to other parties			0
	Cash payments for future contracts, forward contracts, option contracts and swap contracts			0
	Cash receipts from future contracts, forward contracts, option contracts and swap contracts			0
	Dividends received			80000
	Interest received			195830000
	Income taxes paid (refund)			0
	Other inflows (outflows) of cash			0
	Net cash flows from (used in) investing activities	-1732860000
	Cash flows from used in financing activities
	Proceeds from changes in ownership interests in subsidiaries			0
	Payments from changes in ownership interests in subsidiaries			0
	Proceeds from issuing shares			0
	Proceeds from issuing other equity instruments			0
	Payments to acquire or redeem entity's shares			0
	Payments of other equity instruments			0
	Proceeds from exercise of stock options			0
	Proceeds from issuing debentures notes bonds etc			0
	Proceeds from borrowings			3249740000
	Repayments of borrowings			0
	Payments of lease liabilities			109390000
	Dividends paid			65570000
	Interest paid			56400000
	Income taxes paid (refund)			0
	Other inflows (outflows) of cash			0
	Net cash flows from (used in) financing activities			3018380000
	Net increase (decrease) in cash and cash equivalents before effect of exchange rate changes			3484300000
	Effect of exchange rate changes on cash and cash equivalents
	Effect of exchange rate changes on cash and cash equivalents			0
	Net increase (decrease) in cash and cash equivalents			3484300000
	Cash and cash equivalents cash flow statement at beginning of period			189800000
	Cash and cash equivalents cash flow statement at end of period			3674100000